Exclusive: India-made Covid-19 vaccine could be launched as early as Feb | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
Exclusive: India-made Covid-19 vaccine could be launched as early as Feb

Coronavirus chronicle

Reuters
05 November, 2020, 02:50 pm
Last modified: 05 November, 2020, 03:55 pm

Related News

  • Shrimp fry worth Tk1cr seized in Cumilla while being smuggled to India
  • India's alarm over Chinese spying rocks the surveillance industry
  • 31 more people pushed into Bangladesh through Kurigram, C’Nawabganj borders
  • 36 trafficked Bangladeshis return after serving jail terms in India
  • BSF pushes in 23 more people through Satkhira border, says BGB

Exclusive: India-made Covid-19 vaccine could be launched as early as Feb

A launch in February would make COVAXIN the first India-made vaccine to be rolled out

Reuters
05 November, 2020, 02:50 pm
Last modified: 05 November, 2020, 03:55 pm
Representational image. Photo: Collected
Representational image. Photo: Collected

An Indian government-backed Covid-19 vaccine could be launched as early as February - months earlier than expected - as last-stage trials begin this month and studies have so far showed it is safe and effective, a senior government scientist told Reuters.

Bharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year. 

"The vaccine has shown good efficacy," senior ICMR scientist Rajni Kant, who is also a member of its Covid-19 task-force, said at the research body's New Delhi headquarters on Thursday.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"It is expected that by the beginning of next year, February or March, something would be available."

Bharat Biotech could not immediately be contacted.

A launch in February would make COVAXIN the first India-made vaccine to be rolled out.

India's cases of coronavirus infections rose by 50,201 cases on Thursday to 8.36 million, second only to the United States. Deaths rose by 704, with the total now at 124,315. The daily rise in infections and deaths has slowed since a peak in mid-September.

Kant, who is the head of ICMR's research management, policy, planning and coordination cell, said it was up to the health ministry to decide if COVAXIN shots can be given to people even before the third-stage trials are over.

"It has shown safety and efficacy in the phase 1 and 2 trials and in the animal studies - so it is safe but you can't be 100% sure unless the phase 3 trials are over," Kant said.

"There may be some risk, if you are ready to take the risk, you can take the vaccine. If necessary, the government can think of giving the vaccine in an emergency situation."

Health Minister Harsh Vardhan said in September the government was considering granting an emergency authorisation for a Covid-19 vaccine, particularly for the elderly and people in high-risk workplaces.

Several leading vaccine candidates are already in final-stage testing. An experimental vaccine developed by Britain's AstraZeneca is among the most advanced ones, and Britain expects to roll it out in late December or early 2021.

AstraZeneca has signed several supply and manufacturing deals with companies and governments around the world, including with the Serum Institute of India.

Other late-stage vaccines are developed by Moderna Inc, Pfizer Inc with partner BioNTech SE, and Johnson & Johnson.

Top News / World+Biz

COVAXIN / India / Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infograph: TBS
    Businesses set for relief as interim govt eyes major tax & fine cuts
  • How termination of USDA-funded trade facilitation project will affect Bangladesh
    How termination of USDA-funded trade facilitation project will affect Bangladesh
  • File photo of Bangladesh Secretariat. Photo: Collected
    Visitors banned from entering Secretariat on Mondays and Thursdays

MOST VIEWED

  • Google Pay. Photo: Collected
    Google Pay likely coming to Bangladesh soon
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • Shrimp fry worth Tk1cr seized in Cumilla while being smuggled to India
  • India's alarm over Chinese spying rocks the surveillance industry
  • 31 more people pushed into Bangladesh through Kurigram, C’Nawabganj borders
  • 36 trafficked Bangladeshis return after serving jail terms in India
  • BSF pushes in 23 more people through Satkhira border, says BGB

Features

In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

2d | Panorama
The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

3d | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

3d | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

3d | Wheels

More Videos from TBS

The fight between two brothers; Adidas vs Puma

The fight between two brothers; Adidas vs Puma

7h | Others
Trump is again keen to make Canada the 51st state

Trump is again keen to make Canada the 51st state

9h | Others
Trump's tariff strategy and Europe's investment politics, violence or negotiation?

Trump's tariff strategy and Europe's investment politics, violence or negotiation?

10h | Others
Rumours surrounding the Club World Cup: Which club will Ronaldo join?

Rumours surrounding the Club World Cup: Which club will Ronaldo join?

10h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net